ATE521337T1 - Verfahren zur herstellung einer pharmazeutischen co-kristall-zusammensetzung - Google Patents

Verfahren zur herstellung einer pharmazeutischen co-kristall-zusammensetzung

Info

Publication number
ATE521337T1
ATE521337T1 AT08779037T AT08779037T ATE521337T1 AT E521337 T1 ATE521337 T1 AT E521337T1 AT 08779037 T AT08779037 T AT 08779037T AT 08779037 T AT08779037 T AT 08779037T AT E521337 T1 ATE521337 T1 AT E521337T1
Authority
AT
Austria
Prior art keywords
pharmaceutically active
active component
builder
solid particles
supercritical
Prior art date
Application number
AT08779037T
Other languages
English (en)
Inventor
Rosmalen Gerda Maria Van
Gerard Willem Hofland
Original Assignee
Feyecon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Feyecon Bv filed Critical Feyecon Bv
Application granted granted Critical
Publication of ATE521337T1 publication Critical patent/ATE521337T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J3/00—Processes of utilising sub-atmospheric or super-atmospheric pressure to effect chemical or physical change of matter; Apparatus therefor
    • B01J3/008—Processes carried out under supercritical conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
AT08779037T 2007-07-18 2008-07-17 Verfahren zur herstellung einer pharmazeutischen co-kristall-zusammensetzung ATE521337T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07112692 2007-07-18
PCT/NL2008/050490 WO2009011584A2 (en) 2007-07-18 2008-07-17 A method of preparing a pharmaceutical co-crystal composition

Publications (1)

Publication Number Publication Date
ATE521337T1 true ATE521337T1 (de) 2011-09-15

Family

ID=38626724

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08779037T ATE521337T1 (de) 2007-07-18 2008-07-17 Verfahren zur herstellung einer pharmazeutischen co-kristall-zusammensetzung

Country Status (4)

Country Link
US (1) US20100184744A1 (de)
EP (1) EP2170284B1 (de)
AT (1) ATE521337T1 (de)
WO (1) WO2009011584A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201222287D0 (en) 2012-12-11 2013-01-23 Ct For Process Innovation Ltd Methods for making active crystalline materials
PT107166B (pt) * 2013-09-16 2018-12-28 Hovione Farm S A Síntese e engenharia de partículas de cocristais
GB2600463A (en) * 2020-10-30 2022-05-04 Cubic Pharmaceuticals Ltd Process of preparing pharmaceutical solids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
WO2001066091A1 (en) * 2000-03-09 2001-09-13 Astrazeneca Ab Method of preparing solid dispersions
US20070099237A1 (en) * 2005-10-31 2007-05-03 The Regents Of The University Of Michigan Reaction co-crystallization of molecular complexes or co-crystals

Also Published As

Publication number Publication date
US20100184744A1 (en) 2010-07-22
WO2009011584A3 (en) 2009-07-16
EP2170284B1 (de) 2011-08-24
EP2170284A2 (de) 2010-04-07
WO2009011584A2 (en) 2009-01-22

Similar Documents

Publication Publication Date Title
AR088460A1 (es) Formulaciones de etanercept estabilizadas con aminoacidos
AR123811A2 (es) Composiciones de células madre mesenquimáticas purificadas y métodos relacionados
EA200970942A1 (ru) Экстракт пажитника сенного (trigonella foenum-graecum)
CA2672452A1 (en) Tannate salt of rasagiline
WO2010051541A3 (en) Compositions containing delta-9-thc-amino acid esters and process of preparation
WO2010018109A3 (en) Substituted aminotetralines
JP2009505966A5 (de)
FI2887923T3 (fi) Polyoksylilipidin tai polyoksylirasvahapon oftalminen formulaatio ja silmätilojen hoito
CL2008002330A1 (es) Compuestos derivados de alcoholes de 1-fenil-2-piridinilalquilo, inhibidores de la fosfodiesterasa 4 (pde4); proceso de preparacion de dichos compuestos; composiciones farmaceuticas que los contienen; y su uso para preparar medicamentos utiles en la prevencion o tratamiento de asma, bronquitis cronica y epoc.
UA109774C2 (uk) Кристалічні форми саксагліптину та процес його одержання (варіанти)
MX2007009796A (es) Gel conteniendo pirfenidona.
NO20080658L (no) Fremgangsmate for a gjenvinne en polymer fra et flytende medium
IL310113B1 (en) Methods of reducing particle formation and compositions formed thereby
BR112012028711A2 (pt) métodos para a fabricação de uma emulsão de óleo em água, para a preparação de um kit de vacina e para redestilação de uma composição compreendendo 99% de esqualeno ou mais, assim como emulsão de óleo em água e kit
CN105001289A (zh) 一种乙酰氨基阿维菌素的精制方法
MX350862B (es) Acidos de piperidinil naftilacetico.
RU2014146272A (ru) Получение дегареликса
ATE513820T1 (de) Neue benzamidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung, die diese enthält
WO2009011584A3 (en) A method of preparing a pharmaceutical co-crystal composition
WO2016045530A1 (zh) 一种高复溶性及高稳定性的绿原酸冻干粉针
WO2009151498A3 (en) Memantine formulations
MX2009008068A (es) Compuesto macrolido en forma solida, proceso para su preparacion y composicion farmaceutica que lo contiene.
JPWO2006028068A1 (ja) Ｌ−カルニチンの精製方法
KR102066108B1 (ko) 페닐링을 가지는 2종 화합물을 포함하는 화장료 조성물
EP4450069A3 (de) Verfahren zur herstellung nitrosylierter propandiole, diese enthaltende zusammensetzungen und deren medizinische verwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties